Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants
Open Access
- 3 April 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (14) , eaeb3034
Abstract
Psychedelic indolethylamines with therapeutic potential are naturally produced in plants, fungi, and animals. Here, we elucidated the complete N , N -dimethyltryptamine (DMT) biosynthetic pathway in hallucinogenic plant species traditionally used in shamanic rituals for spiritual healing. Leveraging the similarities in their chemical structures, we reconstructed in one plant assay the full biosynthetic pathways of five renowned natural psychedelics; psilocin and psilocybin found in mushrooms, DMT from plants, and bufotenin and 5-methoxy-DMT secreted by the Sonoran Desert toad. We further engineered halogenated analogs of these molecules, which do not naturally occur in plants and exhibit prospective therapeutic potential for psychiatric conditions. Blending catalytic functions across the tree of life, coupled with metabolic engineering guided by rational protein design of mutant enzymes, enabled substantially more efficient in planta production of the indolethylamine components. This work establishes a versatile platform for concurrent biosynthesis and diversification of psychoactive indolethylamines, paving the way for their production in plants.Keywords
Funding Information
- Leona M. and Harry B. Helmsley Charitable Trust
- The Adelis Foundation
- Tom and Sondra Rykoff Family Foundation Research
- Weizmann SABRA - Yeda - Sela - WRC Program
- the Estate of Emile Mimran and The Maurice and Vivienne Wohl 1032 Biology Endowment
- Ron Sklare
- the Jeanne and Joseph Nissim Foundation for Life Sciences
- the Raymond Burton Plant Genome Research Fund
This publication has 67 references indexed in Scilit:
- Secondary Metabolites from Three Florida Sponges with Antidepressant ActivityJournal of Natural Products, 2008
- Structure, function, and evolution of plantO-methyltransferasesGenome, 2007
- A Regioselective Tryptophan 5-Halogenase Is Involved in Pyrroindomycin Biosynthesis in Streptomyces rugosporus LL-42D005Chemistry & Biology, 2005
- Robust in vitro activity of RebF and RebH, a two-component reductase/halogenase, generating 7-chlorotryptophan during rebeccamycin biosynthesisProceedings of the National Academy of Sciences, 2005
- Hallucinogens and dissociative agents naturally growing in the United StatesPharmacology & Therapeutics, 2004
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and PharmacokineticsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Effect of Ring Fluorination on the Pharmacology of Hallucinogenic TryptaminesJournal of Medicinal Chemistry, 2000
- Bufo alvarius: a potent hallucinogen of animal originJournal of Ethnopharmacology, 1994
- 5-Methoxy- and 5-Hydroxyindoles in the skin of Bufo alvariusBiochemical Pharmacology, 1967